ABBV vs DELL: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Dell Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-18.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Dell Technologies Inc. · Technology
$196.55
+154.3% upside to fair value
Grade B
QuantHub Verdict
DELL has more upside to fair value
(+154.3%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
DELL |
| Current Price |
$208.05 |
$196.55 |
| Fair Value Estimate |
$217.50 |
$499.84 |
| Upside to Fair Value |
+4.5%
|
+154.3%
|
| Market Cap |
$367.9B |
$132.7B |
| Forward P/E |
14.9x
|
21.6x
|
| EV / EBITDA |
16.7x
|
16.7x
|
| Price / Sales |
6.1x
|
1.2x
|
| Price / FCF |
20.9x
|
15.5x
|
| Revenue Growth YoY |
+8.6%
|
+23.6%
|
| Gross Margin |
83.7%
|
20.1%
|
| Operating Margin |
34.7%
|
7.2%
|
| Return on Equity |
-129.24%
|
-218.2%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
6.45%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Dell Technologies Inc. is a leading global technology company specializing in computer hardware, servers, storage, and IT infrastructure solutions. Founded and led by Michael Dell, the company has a strong legacy in direct-to-consumer PC sales and has expanded into enterprise IT services through strategic acquisitions such as EMC. Dell's business quality is medium due to its competitive position …
Accumulation Zones
| Metric |
ABBV |
DELL |
| Zone Low |
$163.13 |
$374.88 |
| Zone High |
$184.88 |
$424.86 |
| In Buy Zone? |
No
|
Yes
|